Lipopolysaccharides from Escherichia coli O111:B4, purified by phenol extraction

Cat. No.: XGB673

Lipopolysaccharides from Escherichia coli O111:B4, purified by phenol extraction

Synonym: LPS

  • MDL: MFCD00164401
  • NACRES: NA.25
Product Size
10 mg;25 mg;100 mg
Price
Datasheet
MSDS
Properties
Biological Source
Escherichia coli (O111:B4)
Form
lyophilized powder
Purity
purified by phenol extraction
Quality Level
300
Applications
Lipopolysaccharides (LPSs) are characteristic components of the cell wall of Gram-negative bacteria. LPS and its lipid A part stimulate the cells of the innate immune system through Toll-like receptor 4 (TLR4), which can recognize common pathogen-related molecular patterns (PAMP). Lipopolysaccharides (LPSs) from Escherichia coli O111:B4 have been used for the stimulation of macrophages. They have been used for LPS preconditioning in mice.
Storage
2-8°C
Safety Information
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US)
WGK Germany
WGK 3
Hazard Statements
H300
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0